BSACI guidelines for the management of drug allergy

Clinical and Experimental Allergy

Volumn 39, Issue 1, 2009, Pages 43-61

  Mirakian, R ^a   Ewan, P W ^a   Durham, S R ^b   Youlten, L J F ^c   Dugue P ^d   Friedmann, P S ^e   English, J S ^f   Huber, P A J ^g   Nasser, S M ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c London Allergy Clinic   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^f QUEEN S MEDICAL CENTRE   (United Kingdom)

^g British Society for Allergy and Clinical Immunology   (United Kingdom)

Author keywords

Aspirin; BSACI; Classification of drug allergy; Drug allergy; Drug allergy investigations; Drug challenge; Drug desensitization; Drug intradermal tests; Drug patch tests; Drug provocation; Drug skin prick; General anaesthetic; Guidelines; Local anaesthetic

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; AMPICILLIN; BLEOMYCIN; CARBAMAZEPINE; CHLORPROMAZINE; DAPSONE; ETANERCEPT; FUROSEMIDE; GRISEOFULVIN; HYDRALAZINE; INFLIXIMAB; ISONIAZID; ISOTRETINOIN; MINOCYCLINE; MODAFINIL; MOXIFLOXACIN; NEVIRAPINE; NIFEDIPINE; PENICILLAMINE; PHENOBARBITAL; PHENYTOIN; PIROXICAM; PROCAINAMIDE; PROPRANOLOL; SULFONAMIDE; UNINDEXED DRUG; WARFARIN;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ANGIONEUROTIC EDEMA; ASTHMA; CHOLESTATIC HEPATITIS; CLINICAL IMMUNOLOGY; COMPETENCE; DESENSITIZATION; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG METABOLISM; ERYTHEMA MULTIFORME; EVIDENCE BASED PRACTICE; FIXED DRUG ERUPTION; GENETIC DISORDER; HEMOLYTIC ANEMIA; HUMAN; INTERSTITIAL NEPHRITIS; INTERSTITIAL PNEUMONIA; INTRACUTANEOUS TEST; LOEFFLER PNEUMONIA; LUPUS LIKE SYNDROME; MACULOPAPULAR RASH; MEMBRANOUS GLOMERULONEPHRITIS; MYASTHENIA GRAVIS; NEUTROPENIA; ORGANIZING PNEUMONIA; PATCH TEST; PATIENT CARE; PATIENT EDUCATION; PEMPHIGUS FOLIACEUS; PHOTODERMATOSIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION; PROVOCATION TEST; PURPURA; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SCLERODERMA; SERUM SICKNESS; SKIN MANIFESTATION; SKIN SENSITIZATION; SKIN TEST; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS;

ADULT; AGED; CHILD; DRUG HYPERSENSITIVITY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFANT; MALE; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; RISK FACTORS; SKIN TESTS; YOUNG ADULT;

EID: 58149214213     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03155.x     Document Type: Review

References (158)

1. Powell RJ, Du Toit GL, Siddique N et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007 37 : 631 50.
2. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000 356 : 1255 9.
3. Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In : Davies DM, ed. Textbook of adverse drug reactions. Oxford : Oxford University Press, 1991 18 45.
4. Johansson SG, Hourihane JO, Bousquet J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001 56 : 813 24.
5. Gell PGH, Coombs RRA. Clinical aspects of immunology, 3rd Edn. Oxford : Blackwell Scientific Publications, 1975.
6. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003 139 : 683 93.
7. Harboe T, Johansson SG, Florvaag E, Oman H. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 2007 62 : 1445 50.
8. Chung CH, Mirakhur B, Chan E et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 2008 358 : 1109 17.
9. Bonn D. Adverse drug reactions remain a major cause of death. Lancet 1998 351 : 1183.
10. Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004 329 : 15 9.
11. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998 279 : 1200 5.
12. Bowman L, Carlstedt BC, Black CD. Incidence of adverse drug reactions in adult medical inpatients. Can J Hosp Pharm 1994 47 : 209 16.
13. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007 167 : 1752 9.
14. Demoly P, Gomes ER. Drug hypersensitivities: definition, epidemiology and risk factors. Allerg Immunol (Paris) 2005 37 : 202 6.
15. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ 1998 316 : 1295 8.
16. Waller P, Shaw M, Ho D, Shakir S, Ebrahim S. Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol 2005 59 : 213 9.
17. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther 2000 25 : 355 61.
18. Ebbesen J, Buajordet I, Erikssen J et al. Drug-related deaths in a department of internal medicine. Arch Intern Med 2001 161 : 2317 23.
19. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000 30 : 1144 50.
20. Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001 1 : 305 10.
21. Adkinson Jr. NF. Risk factors for drug allergy. J Allergy Clin Immunol 1984 74 : 567 72.
22. Vervloet D, Durham S. Adverse reactions to drugs. BMJ 1998 316 : 1511 4.
23. deShazo RD, Kemp SF. Allergic reactions to drugs and biologic agents. JAMA 1997 278 : 1895 906.
24. Gruchalla RS. Drug metabolism, danger signals, and drug-induced hypersensitivity. J Allergy Clin Immunol 2001 108 : 475 88.
25. Lang DM, Alpern MB, Visintainer PF, Smith ST. Gender risk for anaphylactoid reaction to radiographic contrast media. J Allergy Clin Immunol 1995 95 : 813 7.
26. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients: a systematic review of the prospective and retrospective studies. Bandolier Extra (Online) June 2002 : 1 15, C, Le CL, de BJ, Le BM, Scheinmann P, Paupe J. Allergy to beta-lactam antibiotics in children. Pediatrics 1999 104 : e45.
27. Co Minh HB, Bousquet PJ, Fontaine C, Kvedariene V, Demoly P. Systemic reactions during skin tests with beta-lactams: a risk factor analysis. J Allergy Clin Immunol 2006 117 : 466 8.
28. Haddi E, Charpin D, Tafforeau M et al. Atopy and systemic reactions to drugs. Allergy 1990 45 : 236 9.
29. Hughes AR, Mosteller M, Bansal AT et al. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 2004 5 : 203 11.
30. Adams LE, Mongey AB. Role of genetic factors in drug-related autoimmunity. Lupus 1994 3 : 443 7.
31. Pirmohamed M. Genetic factors in the predisposition to drug-induced hypersensitivity reactions. AAPS J 2006 8 : E20 6.
32. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984 100 : 495 9.
33. Van Arsdel Jr. P. Pseudoallergic drug reactions. Immunol Allergy Clin North Am 1991 11 : 635 44.
34. Parmar JS, Nasser S. Antibiotic allergy in cystic fibrosis. Thorax 2005 60 : 517 20.
35. Mathelier-Fusade P. Drug-induced urticarias. Clin Rev Allergy Immunol 2006 30 : 19 23.
36. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001 24 : 599 606.
37. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998 18 : 171 88.
38. Kostis JB, Kim HJ, Rusnak J et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005 165 : 1637 42.
39. Slater EE, Merrill DD, Guess HA et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988 260 : 967 70.
40. Lieberman P, Kemp SF, Oppenheimer J et al. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005 115 : S483 S523.
41. Delage C, Irey NS. Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forensic Sci 1972 17 : 525 40.
42. Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999 353 : 1157 8.
43. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2000 53 : 357 79.
44. Drake LA, Dinehart SM, Farmer ER et al. Guidelines of care for cutaneous adverse drug reactions. American Academy of Dermatology. J Am Acad Dermatol 1996 35 : 458 61.
45. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986 256 : 3358 63.
46. Stevenson DD. Adverse reactions to nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 1998 18 : 773 98.
47. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994 331 : 1272 85.
48. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993 129 : 92 6.
49. Molinaro G, Cugno M, Perez M et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. J Pharmacol Exp Ther 2002 303 : 232 7.
50. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo Jr. CA. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008 100 : 327 32.
51. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003 111 : 913 21.
52. Morimoto T, Gandhi TK, Fiskio JM et al. Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough. J Gen Intern Med 2004 19 : 684 91.
53. Rosenow III. EC, Myers JL, Swensen SJ, Pisani RJ. Drug-induced pulmonary disease. An update. Chest 1992 102 : 239 50.
54. Podevin P, Biour M. Drug-induced "allergic hepatitis". Clin Rev Allergy Immunol 1995 13 : 223 44.
55. Castell JV, Castell M. Allergic hepatitis induced by drugs. Curr Opin Allergy Clin Immunol 2006 6 : 258 65.
56. Simpson IJ, Marshall MR, Pilmore H et al. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Nephrology (Carlton) 2006 11 : 381 5.
57. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996 15 : 250 7.
58. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006 55 : 1 8.
59. Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006 155 : 344 9.
60. Gruchalla RS. Clinical assessment of drug-induced disease. Lancet 2000 356 : 1505 11.
61. Nimmo W, Bogod D, McNicol L et al. Suspected anaphylactic reactions associated with anaesthesia, 3rd Edn. Report by the Association of Anaesthetists of Great Britain and Ireland and British Society for Allergy and Clinical Immunology, 2003.
62. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987 316 : 1622 6.
63. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989 83 : 1551 5.
64. Schwartz LB, Kepley C. Development of markers for human basophils and mast cells. J Allergy Clin Immunol 1994 94 : 1231 40.
65. Schwartz LB. Effector cells of anaphylaxis: mast cells and basophils. Novartis Found Symp 2004 257 : 65 74.
66. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003 99 : 536 45.
67. Edston E, van Hage-Hamsten M. Beta-tryptase measurements post-mortem in anaphylactic deaths and in controls. Forensic Sci Int 1998 93 : 135 42.
68. Brockow K, Jofer C, Ring J. Anaphylaxis in patients with mastocytosis - a prospective study on prevalence, severity and trigger factors in 121 patients. J Allergy Clin Immunol 2006 117 : S307.
69. Gruchalla RS, Pirmohamed M. Clinical practice. Antibiotic allergy. N Engl J Med 2006 354 : 601 9.
70. Tamayo E, Alvarez FJ, Rodriguez-Ceron G, Gomez-Herreras JI, Castrodeza J. Prevalence of positive prick test to anaesthetic drugs in the surgical population. Allergy 2006 61 : 952 3.
71. Markman M, Zanotti K, Peterson G, Kulp B, Webster K, Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 2003 21 : 4611 4.
72. Tamayo E, Rodriguez-Ceron G, Gomez-Herreras JI, Fernandez A, Castrodeza J, Alvarez FJ. Prick-test evaluation to anaesthetics in patients attending a general allergy clinic. Eur J Anaesthesiol 2006 23 : 1031 6.
73. Moneret-Vautrin DA, Kanny G. Anaphylaxis to muscle relaxants: rational for skin tests. Allerg Immunol (Paris) 2002 34 : 233 40.
74. Zanotti KM, Rybicki LA, Kennedy AW et al. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 2001 19 : 3126 9.
75. Macy E, Burchette RJ. Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up. Allergy 2002 57 : 1151 8.
76. Sogn DD, Evans III. R, Shepherd GM et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992 152 : 1025 32.
77. Green GR, Rosenblum AH, Sweet LC. Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy. J Allergy Clin Immunol 1977 60 : 339 45.
78. Rodriguez-Bada JL, Montanez MI, Torres MJ et al. Skin testing for immediate hypersensitivity to betalactams: comparison between two commercial kits. Allergy 2006 61 : 947 51.
79. Solensky R. Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol 2003 24 : 201 20.
80. Macy E, Mangat R, Burchette RJ. Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol 2003 111 : 1111 5.
81. Bittner A, Greenberger PA. Incidence of resensitization after tolerating penicillin treatment in penicillin-allergic patients. Allergy Asthma Proc 2004 25 : 161 4.
82. Gadde J, Spence M, Wheeler B, Adkinson Jr. NF. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993 270 : 2456 63.
83. Torres MJ, Mayorga C, Leyva L et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy 2002 32 : 270 6.
84. Torres MJ, Blanca M, Fernandez J et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003 58 : 961 72.
85. Bousquet PJ, Kvedariene V, Co-Minh HB et al. Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy 2007 62 : 872 6.
86. Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 2008 38 : 185 90.
87. Gruchalla RS. 10. Drug allergy. J Allergy Clin Immunol 2003 111 : S548 59.
88. Gueant JL, Gueant-Rodriguez RM, Viola M, Valluzzi RL, Romano A. IgE-mediated hypersensitivity to cephalosporins. Curr Pharm Des 2006 12 : 3335 45.
89. Romano A, Gueant-Rodriguez RM, Viola M et al. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005 35 : 1234 42.
90. Antunez C, Blanca-Lopez N, Torres MJ et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 2006 117 : 404 10.
91. Antunez C, Martin E, Cornejo-Garcia JA et al. Immediate hypersensitivity reactions to penicillins and other betalactams. Curr Pharm Des 2006 12 : 3327 33.
92. Porri F, Lemiere C, Birnbaum J et al. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 1999 29 : 72 5.
93. Fraser BA, Smart JA. Anaphylaxis to cisatracurium following negative skin testing. Anaesth Intensive Care 2005 33 : 816 9.
94. Fisher MM, Merefield D, Baldo B. Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia. Br J Anaesth 1999 82 : 770 3.
95. Leguy-Seguin V, Jolimoy G, Coudert B et al. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immunol 2007 119 : 726 30.
96. Enrique E, Malek T, Castello JV, de Mateo JA. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin. Ann Allergy Asthma Immunol 2008 100 : 86.
97. Leynadier F, Sansarricq M, Didier JM, Dry J. Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 1987 59 : 683 9.
98. Weiss ME, Adkinson NF, Tilles SA. Diagnostic testing for drug hypersensitivity. Immunol Allergy Clin North Am 1998 18 : 731 44.
99. Demoly P, Michel F-B, Bousquet J. In-vivo methods for study of allergy, skin tests: techniques and interpretation. In : Middleton EJ, Reed C, Ellis EF, Yunginger JW, eds. Allergy: principles and practice. London : Mosby, 1998 430 9.
100. Bernstein IL, Gruchalla R, Lee R et al. Disease management of drug hypersensitivity: a practice parameter. Ann Allergy, Asthma Immunol 1999 83 : 665 700.
101. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002 57 : 45 51.
102. Maria Y, Grosdidier R, Haberer JP, Moneret-Vautrin DA. Prospective preoperative survey of 300 patients using prick tests with muscle relaxants. Ann Fr Anesth Reanim 1989 8 : 301 5.
103. Empedrad R, Darter AL, Earl HS, Gruchalla RS. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003 112 : 629 30.
104. Weber-Mani U, Pichler WJ. Anaphylactic shock after intradermal testing with betalactam antibiotics. Allergy 2008 63 : 785.
105. Gruchalla R. Understanding drug allergies. J Allergy Clin Immunol 2000 105 : S637 44.
106. Romano A, Blanca M, Torres MJ et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004 59 : 1153 60.
107. Torres MJ, Sanchez-Sabate E, Alvarez J et al. Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004 59 : 219 24.
108. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005 152 : 968 74.
109. Barbaud A, Reichert-Penetrat S, Trechot P et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998 139 : 49 58.
110. Wolkenstein P, Chosidow O, Flechet ML et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996 35 : 234 6.
111. Fontaine C, Mayorga C, Bousquet PJ et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 2007 62 : 47 52.
112. Primeau MN, Adkinson Jr. NF Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol 2001 1 : 337 41.
113. Hamilton RG, Franklin Adkinson J. In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol 2004 114 : 213 25.
114. Aberer W, Bircher A, Romano A et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003 58 : 854 63.
115. Torres MJ, Romano A, Mayorga C et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001 56 : 850 6.
116. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007 62 : 1111 8.
117. Greenberger PA, Tilles SA. Drug Challenge and desensitization protocols. Immunol Allergy Clin North Am 1998 18 : 759 72.
118. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004 140 : 1001 6.
119. Ewan PW, Ackroyd JF. Allergic reactions to drugs. In : Wright DJM, ed. Immunology of sexually transmitted diseases. London : Kluwer Academic Publisher, 1988 237 60.
120. Greenberger PA. Immunotherapy update: mechanisms of action. Allergy Asthma Proc 2002 23 : 373 6.
121. Solensky R, Earl HS, Gruchalla RS. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 2002 162 : 822 6.
122. Langley JM, Halperin SA, Bortolussi R. History of penicillin allergy and referral for skin testing: evaluation of a pediatric penicillin allergy testing program. Clin Invest Med 2002 25 : 181 4.
123. Carleton BC, Smith MA, Gelin MN, Heathcote SC. Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol 2007 14 : e45 57.
124. Rebelo GE, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy 2008 38 : 191 8.
125. Orhan F, Karakas T, Cakir M et al. Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren. Pediatr Allergy Immunol 2008 19 : 82 5.
126. Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol 2008 19 : 634 8.
127. Martin-Munoz F, Moreno-Ancillo A, Dominguez-Noche C et al. Evaluation of drug-related hypersensitivity reactions in children. J Investig Allergol Clin Immunol 1999 9 : 172 7.
128. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001 52 : 77 83.
129. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006 118 : 555 62.
130. Segal AR, Doherty KM, Leggott J, Zlotoff B. Cutaneous reactions to drugs in children. Pediatrics 2007 120 : e1082 96.
131. Rosario NA, Grumach AS. Allergy to beta-lactams in pediatrics: a practical approach. J Pediatr (Rio J) 2006 82 : S181 8.
132. Ponvert C, Weilenmann C, Wassenberg J et al. Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy 2007 62 : 42 6.
133. Atanaskovic-Markovic M, Velickovic TC, Gavrovic-Jankulovic M, Vuckovic O, Nestorovic B. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol 2005 16 : 341 7.
134. Perez-Rodriguez E, Martin-Conde L, Sanchez-Machin I, Garcia-Robaina JC, de la TF, Matheu V. Beta-lactam allergy in children. Pediatr Allergy Immunol 2006 17 : 236 7.
135. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005 115 : 1048 57.
136. Stevenson DD, Woessner KM, Simon RA, Namazy JA, Lang DM. Evidence-based protocols for oral NSAID challenges. J Pediatr 2006 148 : 704 5.
137. Sanchez-Borges M, Capriles-Behrens E, Caballero-Fonseca F. Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood. Pediatr Allergy Immunol 2004 15 : 376 80.
138. Boussetta K, Ponvert C, Karila C, Bourgeois ML, Blic J, Scheinmann P. Hypersensitivity reactions to paracetamol in children: a study of 25 cases. Allergy 2005 60 : 1174 7.
139. Kidon MI, Kang LW, Chin CW et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics 2005 116 : e675 80.
140. Stark BJ, Earl HS, Gross GN, Lumry WR, Goodman EL, Sullivan TJ. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. J Allergy Clin Immunol 1987 79 : 523 32.
141. Lee CW, Matulonis UA, Castells MC. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 2004 95 : 370 6.
142. Feldweg AM, Lee CW, Matulonis UA, Castells M. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Gynecol Oncol 2005 96 : 824 9.
143. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization-treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990 85 : 59 65.
144. Macy E, Bernstein JA, Castells MC et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol 2007 98 : 172 4.
145. Sullivan TJ. Drug allergy. In : Middleton E, ed. Allergy: principles and practice. 4th ed. St Louis MO : Mosby, 1993 1726 46.
146. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997 277 : 301 6.
147. Chung WH, Hung SI, Hong HS et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004 428 : 486.
148. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions - new concepts. Clin Exp Allergy 2007 37 : 989 99.
149. Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997 52 : 388 93.
150. Cooper SC, Ford LT, Berg JD, Lewis MJ. Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population study. Pharmacogenomics 2008 9 : 303 9.
151. MHRA. Pabrinex: allergic reactions. Claire Tilstone, Vol. 1, Issue 2, 8. Report by the Medicines and Healthcare products Regulatory Agency, Commission on Human Medicines, Drug Safety Update, 2008.
152. Lenler-Petersen P, Hansen D, Andersen M, Sorensen HT, Bille H. Drug-related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995 48 : 1185 8.
153. Roujeau JC, Kelly JP, Naldi L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995 333 : 1600 7.
154. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001 137 : 357 64.
155. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002 8 : 5.
156. Peyriere H, Dereure O, Breton H et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006 155 : 422 8.
157. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol 2001 28 : 113 9.
158. Knopp EA, Cowper SE. Nephrogenic systemic fibrosis: early recognition and treatment. Semin Dial 2008 21 : 123 8.